Search the Newsreel

Corbus Pharmaceuticals Holdings Inc (CRBP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article from TradingKey provides a historical overview of Corbus Pharmaceuticals Holdings Inc (CRBP) dividends and stock splits. It notes that no dividends have been distributed in the past five years and details multiple merger-related stock splits that occurred on February 13, 2023, with …

Corbus Pharmaceuticals Market Sentiment

This article analyzes the market sentiment for Corbus Pharmaceuticals (CRBP) based on analyst consensus, short interest, options flow, and insider activity. The analyst consensus is 'Buy' with a significant average price target upside, while short interest is rising. Although the options flow is bullish, …

Corbus Pharmaceuticals Holdings Inc (CRBP) Balance Sheet - Tradingkey.com

This article provides a detailed balance sheet for Corbus Pharmaceuticals Holdings Inc (CRBP), offering quarterly and annual financial data essential for evaluating the company's financial health. It includes key metrics such as cash, total assets, liabilities, and shareholders' equity, along with year-over-year percentage changes. …

TradingKey

This article presents the quarterly and annual income statements for Corbus Pharmaceuticals Holdings Inc. (CRBP) from FY2013Q1 through FY2026Q1, detailing revenue, operating expenses, R&D expenses, depreciation, operating profit, non-operating income/expenses, income before tax, net income, and earnings per share. It also includes an FAQ …

CRBP|Corbus Pharmaceuticals Holdings Inc|Price:9.170|Chg%:-0.150

This article provides a detailed financial overview of Corbus Pharmaceuticals Holdings Inc (CRBP), including its latest stock price, market capitalization, earnings, and forecasts. It presents a comprehensive data dashboard with income statements, balance sheets, and cash flow statements, enabling investors to analyze the company's …

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Passes Above 50-Day Moving Average - What's Next?

Corbus Pharmaceuticals Holdings Inc. Stock Climbs 5.4%, Outperforms Peers

Shares of Corbus Pharmaceuticals Holdings Inc. increased by 5.4% to $9.32, outperforming a general market downturn where the NASDAQ Composite Index fell 2.2% and the Dow Jones Industrial Average fell 1.0%. The company's stock closed significantly

Corbus Pharmaceuticals stock steadies as pipeline advances after equity raise

Corbus Pharmaceuticals' stock is gaining attention following a recent equity offering that strengthened its financial position. The biotech company is progressing with its lead antibody-drug conjugate, CRB-701, for which Phase 1 data is advancing, and is preparing two other oncology programs, CRB-601 and CRB-913, …

(CRBP) as a Liquidity Pulse for Institutional Tactics

This article analyzes Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) using AI models to provide institutional trading strategies. It highlights stable neutral readings in shorter timeframes possibly signaling an easing of a long-term weak bias, and identifies a significant 156.0:1 risk-reward setup. The analysis includes …

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market

Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its stock rise by 1.01% on Tuesday, closing at $8.98. Despite this increase, the stock underperformed the broader market, as both the NASDAQ Composite and Dow Jones Industrial Average also climbed. The company's shares remain significantly below their …